Arikayce Liposomal
(asked on 16th May 2022) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when Arikayce Liposomal will be available to patients with non-tuberculosis mycobacteria.
This question was answered on 24th May 2022
It is expected that Arikayce liposomal will be considered by the Clinical Priorities Advisory Group (CPAG) in July 2022. Following receipt of the CPAG’s advice, decisions on funding will be made, with the commissioning of those treatments prioritised for investment beginning within the current financial year.